The National Agency for Food and Drugs Administration and Control (NAFDAC) is writing to inform the public about the circulation of counterfeit Combiart Dispersible Tablet 20/120mg in the country. The product is manufactured by Strides Arcolab Limited, based in India.

This product was discovered in the FCT and Rivers State, during surveillance activities conducted by officers of the Post Marketing Surveillance Directorate of NAFDAC.

The laboratory report of the analysis carried out on the product revealed that it contained zero APIs. The product was also observed to have two different date markings. The NAFDAC database of registered products has confirmed that the product license has expired, and the NAFDAC Registration Number on it is wrong and not for the product.

COMBIART (Artemether + Lumefantrine 20/120mg): The Artemether and Lumefantrine combination belongs to a group of medicines known as antimalarials. It treats malaria, a red blood cell infection transmitted by the bite of a mosquito. However, this medicine is not used to treat severe or complicated malaria.

Risk Statement

Counterfeit or falsified medicines endanger people’s health because they do not comply with regulatory standards, which means the safety, quality, and efficacy of these products are not ensured. The use of counterfeit medicines often fails to effectively treat diseases or conditions, leading to serious health consequences, including death.

Product details

The details of the product are as follows:

Brand Name: Combiart Dispersible Tablet 20/120mg

Generic Name: Artemether + Lumefantrine 20/120mg Dispersible Tablet

Batch No: 7225119

NAFDAC Reg No: A11-0299

Manufacturing Date: June 2023 and Feb 2023

Expiry Date: May 2026 and June 2026

Manufacturer’s Name and Address: Strides Arcolab Limited, 36/7, Suragajakkanahalli, Indlavadi Cross, Anekal Taluk, Bangalore- 562 106, India.